Vaxcyte, Inc.

PCVX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$387,878$397,451$834,657$68,985
Short-Term Investments$1,359,330$682,776$96,719$176,985
Receivables$20,662$3,607$0$0
Inventory$0$0$0$0
Other Curr. Assets$20,115$12,120$11,179$10,378
Total Curr. Assets$1,787,985$1,095,954$942,555$256,348
Property Plant & Equip (Net)$270,147$110,623$31,648$35,912
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$1,387,510$162,675$26,549$27,117
Tax Assets$0$0$0$0
Other NC Assets$65,676$38,665$5,426$4,960
Total NC Assets$1,723,333$311,963$63,623$67,989
Other Assets$0$0$0$0
Total Assets$3,511,318$1,407,917$1,006,178$324,337
Liabilities
Payables$48,452$14,587$9,795$6,758
Short-Term Debt$5,891$7,113$5,910$5,276
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$85,837$123,638$24,820$16,682
Total Curr. Liab.$140,180$145,338$40,525$28,716
LT Debt$65,219$22,111$12,031$11,507
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$100$0$9$96
Total NC Liab.$65,319$22,111$12,040$11,603
Other Liabilities$0$0$0$0
Cap. Leases$71,110$29,224$17,941$16,783
Total Liabilities$205,499$167,449$52,565$40,319
Equity
Pref Stock$0$0$0$0
Common Stock$128$98$82$56
Retained Earnings-$1,388,319-$924,392-$522,126-$298,641
AOCI-$3,873$179-$361-$241
Other Equity$4,697,883$2,164,583$1,476,018$582,844
Total Equity$3,305,819$1,240,468$953,613$284,018
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,511,318$1,407,917$1,006,178$324,337
Net Debt-$316,768-$368,227-$816,716-$52,202